Free Express Shipping on Orders $450+ | Peptide of the Week: GHK-Cu - 10% Off This Week

Melanotan 1 vs Melanotan 2: Research Comparison 2026

Melanotan 1 (MT1) and Melanotan 2 (MT2) are synthetic melanocortin peptides derived from alpha-melanocyte-stimulating hormone, but they are not interchangeable research tools. MT1 is a linear, afamelanotide-related peptide studied primarily for MC1R-selective peripheral melanocortin signaling, while MT2 is a cyclic lactam analogue studied for broader melanocortin receptor activity across peripheral and central pathways.

Research-use-only materials for qualified laboratory and research settings. Batch-specific documentation and third-party testing standards apply.

Page updated: June 17, 2026 Canada and USA Research Comparison Melanocortin Receptor Research Research Use Only
Direct Answer

Melanotan 1 (MT1, afamelanotide-related, CAS 75921-69-6) is a linear synthetic melanocortin peptide studied primarily for selective MC1R interaction and peripheral pigmentation-related signaling models. Melanotan 2 (MT2, CAS 121062-08-6) is a cyclic lactam analogue studied for broader melanocortin receptor engagement across MC1R, MC3R, and MC4R. MT1 is the more targeted MC1R research compound, while MT2 is the broader melanocortin research compound.

What this comparison covers
Molecular Structure
Receptor Profiles
BBB Context
Research Fit
Sourcing Standards
Key Takeaways
  • MT1 is best understood as a linear, afamelanotide-related melanocortin peptide studied mainly for MC1R-selective peripheral pathway research.
  • MT2 is a cyclic lactam melanocortin analogue studied for broader receptor engagement, including MC1R, MC3R, and MC4R.
  • The core structural distinction is linear MT1 versus cyclic MT2, which affects receptor access, stability, and research interpretation.
  • Researchers looking for tighter MC1R pathway isolation should evaluate MT1. Researchers studying broader melanocortin receptor activity should evaluate MT2.
  • Both compounds require batch-specific documentation, third-party purity testing, careful cold-chain handling, and research-use-only positioning.
Melanotan 1 (MT1)

What Is Melanotan 1?

Melanotan 1 (MT1) is a synthetic linear melanocortin peptide studied primarily for selective interaction with the melanocortin-1 receptor (MC1R). It is closely associated with afamelanotide-class compounds in the research literature and is commonly discussed in relation to pigmentation signaling, melanocyte biology, and peripheral MC1R pathway models.

Its linear structure limits blood-brain barrier permeability, keeping its primary research profile focused on peripheral receptor pathways rather than central melanocortin signaling. This makes MT1 a more targeted research tool when the objective is to isolate MC1R-related activity from broader MC3R and MC4R pathway involvement.

For a deeper standalone review of MT1 structure, receptor relevance, research context, and handling considerations, see the Melanotan I (MT1) Research Guide.

Best Research Fit

MT1 is the more selective melanocortin research tool. It is studied mainly for MC1R signaling and peripheral pigmentation-pathway models, without the same broad central receptor profile associated with MT2.

Melanotan 2 (MT2)

What Is Melanotan 2?

Melanotan 2 (MT2) is a synthetic cyclic lactam analogue of alpha-melanocyte-stimulating hormone. Its cyclic structure differentiates it fundamentally from MT1 and contributes to a broader receptor profile across MC1R, MC3R, and MC4R.

This broader receptor engagement makes MT2 more commonly referenced in multi-pathway melanocortin research, neuroendocrine signaling models, appetite and energy-balance pathway studies, and comparative receptor activity investigations.

Best Research Fit

MT2 is the broader melanocortin research tool. Its cyclic structure gives it a wider receptor profile than MT1, which means it can introduce more experimental variables and requires tighter study design controls.

Jump to a section

MT1 or MT2: Which Research Peptide Fits the Study Design?

The correct compound depends on the receptor question being studied. MT1 and MT2 should not be selected based on name similarity. They should be selected based on receptor selectivity, central pathway relevance, and experimental design.

Choose MT1 when the research focus is MC1R selectivity

MT1 is the better fit when a study needs a cleaner, more targeted melanocortin profile centered on MC1R and peripheral signaling.

  • MC1R-focused research design
  • Peripheral melanocortin signaling models
  • Lower receptor-variable complexity
  • Afamelanotide-related peptide research context

Choose MT2 when the research focus is broader receptor activity

MT2 is the better fit when a study requires broader melanocortin receptor activity across MC1R, MC3R, and MC4R.

  • Multi-receptor melanocortin research
  • MC3R and MC4R pathway relevance
  • Central and peripheral pathway modeling
  • Cyclic lactam peptide research context

Molecular Profiles

MT1 and MT2 share a common origin in alpha-MSH-related melanocortin peptide chemistry, but their structural differences produce meaningfully different research-use profiles.

MT1 CAS 75921-69-6
MT1 Structure Linear peptide
MT2 CAS 121062-08-6
MT2 Structure Cyclic lactam
Luxara Purity ≥99%
Property Melanotan 1 (MT1) Melanotan 2 (MT2)
Full classification Synthetic linear melanocortin peptide, afamelanotide-related Synthetic cyclic lactam analogue of alpha-MSH
CAS number 75921-69-6 121062-08-6
Structural conformation Linear peptide chain Cyclic lactam ring structure
Origin compound Analogue derived from alpha-melanocyte-stimulating hormone Cyclic analogue derived from alpha-melanocyte-stimulating hormone with conformational modification
Blood-brain barrier permeability Poor in standard research models, primarily peripheral activity Greater central-access profile than MT1 due to cyclic structure
Research selectivity More selective for MC1R-centered research questions Broader melanocortin receptor research profile
Luxara Labs purity standard ≥99% with third-party HPLC and MS documentation ≥99% with third-party HPLC and MS documentation

The Melanocortin System: Research Context

The practical difference between MT1 and MT2 comes down to receptor access and receptor selectivity. Both belong to the broader melanocortin research family, but they are used to answer different experimental questions.

Definition: The Melanocortin System

The melanocortin system consists of five G-protein-coupled receptors, MC1R through MC5R. MC1R is strongly associated with melanocyte and pigmentation-pathway research. MC3R and MC4R are centrally expressed and are commonly studied in energy balance, appetite signaling, and neuroendocrine pathway models. MC2R is the ACTH receptor, while MC5R is associated with exocrine gland and peripheral tissue signaling.

Receptor Primary Location Associated Research Context MT1 Activity MT2 Activity
MC1R Melanocytes, skin, peripheral tissue Pigmentation signaling, melanocyte biology, photoprotection-pathway research Primary target Active
MC2R Adrenal cortex ACTH receptor biology Not a primary target Not a primary target
MC3R Brain, hypothalamus, peripheral tissue Energy homeostasis, appetite signaling, metabolic pathway research Minimal central activity Active in central-context models
MC4R Brain, hypothalamus, brainstem Energy balance, neuroendocrine signaling, behavioral pathway research Minimal central activity Active in central-context models
MC5R Exocrine glands, skin, peripheral tissue Exocrine gland and peripheral signaling research Limited Limited
Research implication: MT1 is better suited to research designs where MC1R isolation matters. MT2 is better suited to broader melanocortin studies where MC3R and MC4R pathway involvement is part of the experimental question. That broader profile can be useful in the right model, but it also increases interpretive complexity.

Receptor Profiles: MT1 vs MT2

Receptor selectivity is the most important practical distinction between MT1 and MT2. The compounds should not be treated as interchangeable simply because both belong to the melanocortin peptide category.

Research Dimension Melanotan 1 (MT1) Melanotan 2 (MT2)
Receptor selectivity Higher selectivity toward MC1R Broader engagement across MC1R, MC3R, and MC4R
Primary receptor context MC1R-centered peripheral research Peripheral and central melanocortin receptor research
Research emphasis Pigmentation signaling, melanocyte biology, MC1R-specific models Multi-pathway melanocortin research, neuroendocrine signaling, appetite and energy-balance models
Research scope Narrower, useful when MC1R isolation is the research objective Broader, useful when multi-receptor melanocortin engagement is the research objective
Experimental controls Fewer receptor variables to account for More receptor variables and central-pathway controls to account for
Research design note: neither compound is superior in an absolute sense. MT1 is the cleaner tool for MC1R-focused designs. MT2 is the broader tool for multi-receptor melanocortin signaling models. The correct selection depends on the pathway being studied.

Blood-Brain Barrier Context: The Critical Structural Difference

The most functionally important difference between MT1 and MT2 is how structure affects receptor access. MT1 is linear. MT2 is cyclic. That structural difference changes the way each compound is studied in peripheral and central melanocortin models.

Feature Melanotan 1 (MT1) Melanotan 2 (MT2)
Structural conformation Linear peptide chain Cyclic lactam ring structure
Blood-brain barrier profile Poor permeability in standard research models Greater central-access profile than MT1 due to cyclic conformation
Central receptor access Limited access to centrally expressed MC3R and MC4R pathways Greater relevance to MC3R and MC4R central pathway research
Research scope implication Peripheral-only or primarily peripheral research design Peripheral and central melanocortin research design
Metabolic stability Moderate, with linear peptide susceptibility to enzymatic cleavage Greater conformational stability due to cyclic structure
Research complexity Lower complexity because fewer receptor systems are involved Higher complexity because central receptor engagement can affect multiple pathways
Research framing reminder: MT2's broader receptor access is not automatically better. It means MT2 introduces more receptor variables into a research model. Researchers seeking clean MC1R isolation should generally evaluate MT1. Researchers studying broader central melanocortin signaling may require MT2.

MT1 vs MT2: Full Comparison Table

The table below summarizes the most important practical differences between Melanotan 1 and Melanotan 2 for research planning, compound selection, and documentation review.

Feature Melanotan 1 (MT1) Melanotan 2 (MT2)
CAS number 75921-69-6 121062-08-6
Structural type Linear peptide Cyclic lactam analogue
Derived from Alpha-melanocyte-stimulating hormone Alpha-melanocyte-stimulating hormone with cyclic modification
Primary receptor focus MC1R MC1R, MC3R, MC4R
Receptor selectivity Higher MC1R selectivity Lower selectivity, broader melanocortin receptor profile
Blood-brain barrier profile Poor permeability, primarily peripheral research activity Greater central-access profile, central and peripheral research activity
Central receptor relevance Limited relevance to central MC3R and MC4R models Relevant to central MC3R and MC4R pathway models
Primary research focus Pigmentation signaling, melanocyte biology, MC1R pathway research Multi-pathway melanocortin research, neuroendocrine signaling, appetite and energy-balance modeling
Research complexity Lower, with fewer receptor variables Higher, with broader receptor involvement
Literature scope More narrow, MC1R and pigmentation-focused Broader, melanocortin and neuroendocrine-focused
Canadian regulatory status Not approved for therapeutic use, research use only Not approved for therapeutic use, research use only
Luxara Labs purity standard ≥99% with third-party HPLC and MS documentation ≥99% with third-party HPLC and MS documentation
Lyophilized storage -20°C, protected from light and moisture -20°C, protected from light and moisture
Post-reconstitution storage 2-8°C, protected from light 2-8°C, protected from light

Compare Current MT1 and MT2 Research Product Details

After comparing receptor selectivity and structural differences, researchers should review current product-specific details, lot documentation, storage notes, and availability before selecting material for a study.

Research Summary

MT1 and MT2 are best separated by structure, receptor selectivity, and receptor access. MT1 is linear and more MC1R-focused, making it useful for peripheral melanocortin pathway research where selective MC1R interpretation matters. MT2 is cyclic and broader, making it relevant to studies where MC1R, MC3R, and MC4R signaling may all be part of the research model.

  • MT1: linear, afamelanotide-related, MC1R-focused, peripheral pathway emphasis.
  • MT2: cyclic lactam analogue, broader receptor profile, central and peripheral pathway emphasis.
  • Main difference: MT2's cyclic structure gives it a wider research profile and greater receptor-access complexity.
  • Selection logic: choose MT1 for MC1R isolation and MT2 for broader melanocortin receptor modeling.

Storage, Handling, and Sourcing Standards

Both MT1 and MT2 require careful handling to preserve research-grade integrity. Purity, documentation, temperature control, and lot traceability are especially important for melanocortin peptides because small differences in material quality can affect downstream interpretation.

Parameter MT1 Standard MT2 Standard
Lyophilized storage -20°C, protected from light and moisture -20°C, protected from light and moisture
Post-reconstitution storage 2-8°C, protected from light, used within the validated research window 2-8°C, protected from light, used within the validated research window
Freeze-thaw cycles Minimize repeated freeze-thaw exposure to protect peptide integrity Minimize repeated freeze-thaw exposure even with greater cyclic stability
Purity requirement ≥99% with independent third-party HPLC and MS documentation ≥99% with independent third-party HPLC and MS documentation
COA requirement Batch-specific documentation with lot traceability Batch-specific documentation with lot traceability
Domestic shipping advantage Reduced transit time, fewer customs variables, better temperature-control reliability Reduced transit time, fewer customs variables, better temperature-control reliability

Frequently Asked Questions

These answers address common research questions about Melanotan 1 and Melanotan 2 from Canadian and US researchers.

The primary difference is structure and receptor selectivity. MT1 is a linear peptide studied mainly for MC1R-selective peripheral melanocortin signaling. MT2 is a cyclic lactam analogue studied for broader melanocortin receptor activity across MC1R, MC3R, and MC4R.

Researchers should choose MT1 when the goal is MC1R-focused peripheral melanocortin pathway research. Researchers should choose MT2 when the goal is broader melanocortin receptor activity involving MC1R, MC3R, and MC4R.

Yes. MT1 is generally studied as the more MC1R-selective compound, while MT2 is studied as a broader melanocortin receptor agonist with activity across MC1R, MC3R, and MC4R. For research designs that require cleaner MC1R isolation, MT1 is typically the more focused tool.

MT2 has a cyclic lactam structure that gives it a different conformational profile than linear MT1. This structure is associated with broader melanocortin receptor access, including MC3R and MC4R pathway relevance in research models.

MT1 is primarily associated with MC1R-focused research, especially melanocyte and pigmentation-pathway models. MT2 is associated with broader melanocortin receptor engagement, including MC1R, MC3R, and MC4R.

MT1 is a linear peptide and is more susceptible to enzymatic cleavage than cyclic analogues. MT2's cyclic lactam structure gives it greater conformational stability in research models. Both compounds still require proper cold-chain handling and minimal freeze-thaw cycling.

Melanotan 1 is commonly discussed as afamelanotide-related because both belong to the alpha-MSH melanocortin peptide family and are associated with MC1R research. Exact compound identity, CAS number, sequence, lot documentation, and analytical testing should always be reviewed rather than relying only on naming conventions.

Neither MT1 nor MT2 is positioned by Luxara Labs as a therapeutic product for human or veterinary use. Both are handled strictly as research-use-only materials for qualified laboratory and research contexts.

Luxara Labs emphasizes third-party analytical documentation, HPLC purity verification, mass spectrometry identity confirmation, batch-specific Certificates of Analysis, lot traceability, cold-chain handling, and research-use-only labeling.

Scientific References

The following peer-reviewed publications and scientific resources support the melanocortin receptor, structural, and comparative research context discussed on this page.

Research Use Notice: All information on this page is provided for scientific, educational, and laboratory reference only. Neither Melanotan 1 nor Melanotan 2 is presented by Luxara Labs as a therapeutic product for human or veterinary use. No medical, cosmetic, tanning, dosing, injection, performance, treatment, prevention, or sun-protection claims are made or implied. Both compounds are intended strictly for research, laboratory, and in vitro use by qualified researchers only. All sourcing and use must comply with applicable Canadian, US, and international regulations.

Unlock 10% Off Your First Order

Join our list and get an instant 10% discount code — valid for first-time buyers.

10% Popup Email Opt-in